Health

August 28, 2019

Nourianz Approved to Treat Off Episodes of Parkinson’s Disease

August 28, 2019 – The U.S. FDA has approved NourianzTM (istradefylline), manufactured by Kiowa Kirin, for use as an adjunctive treatment for adults who are also taking levodopa/carbidopa, have Parkinson's disease, and are experiencing off episodes.

August 28, 2019

FDA Issues Safety Communication Regarding Use of Hepatitis C Drugs

August 28, 2019 – The U.S. FDA has received reports of rare worsening liver function or liver failure in patients with moderate to severe liver impairment who have received the following treatments for chronic hepatitis C virus (HCV)

August 26, 2019

Taltz Receives New Indication for Ankylosing Spondylitis

August 26, 2019 – The U.S. FDA has approved a new indication for Taltz® (ixekizumab), manufactured by Eli Lilly. The product is now indicated to treat adult patients who have active ankylosing spondylitis (AS), also known as radiographic axial spondyloarthritis (r-axSpA).

August 21, 2019

Nourianz Approved to Treat Off Episodes of Parkinson’s Disease

FDA Issues Safety Communication Regarding Use of Hepatitis C Drugs

Taltz Receives New Indication for Ankylosing Spondylitis

Brand Medications with Generic Alternatives Anticipated to be Approved in October

Myobloc Receives New Indication

Ultomiris Approved to Treat Rare Blood Disorder